Pediatrix Medical beats Q1 revenue and adjusted EBITDA estimates

Pediatrix Medical

05/05/2026 11:09

Overview

US physician services provider exceeded analyst expectations for Q1 revenue

Adjusted EBITDA beat consensus

Company reaffirmed full-year 2026 adjusted EBITDA outlook

Outlook

Pediatrix reaffirms 2026 full-year Adjusted EBITDA outlook of $280 mln to $300 mln

Company says 2026 priorities focus on quality-driven support for hospital partners

Pediatrix says robust cash flow and healthy balance sheet position it for new opportunities

Result Drivers

SAME-UNIT REVENUE GROWTH - Co said Q1 revenue growth was primarily driven by a 2.8% increase in same-unit revenue, reflecting improved cash collections, higher hospital contract administrative fees, increased patient acuity in neonatology, and a slightly favorable shift in payor mix

ACQUISITIONS - Recent acquisitions contributed to non-same unit revenue growth, partially offset by practice dispositions

PATIENT VOLUME DECLINE - Same-unit patient volume decreased by 1.6%

Company press release: ID:nBw3NCDpya

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Revenue
Beat
$476.20 mln
$465.83 mln (7 Analysts)
Q1 EPS
$0.36
Q1 Net Income
$29.57 mln
Q1 Adjusted EBITDA
Beat
$58.15 mln
$51.33 mln (7 Analysts)
Q1 Income from operations
$41.66 mln
Q1 Operating Expenses
$434.54 mln


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", 5 "hold" and no "sell" or "strong sell"

The average consensus recommendation for the healthcare facilities & services peer group is "buy"

Wall Street's median 12-month price target for Pediatrix Medical Group Inc is $21.50, about 4.1% below its May 4 closing price of $22.41

The stock recently traded at 10 times the next 12-month earnings vs. a P/E of 10 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)